Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses

In the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans...

Full description

Bibliographic Details
Main Authors: Crystal A. Mendoza, Hideki Ebihara, Satoko Yamaoka
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/7/4/125
id doaj-4de3680823044500a501165bfa2dadb2
record_format Article
spelling doaj-4de3680823044500a501165bfa2dadb22020-11-24T20:53:06ZengMDPI AGVaccines2076-393X2019-09-017412510.3390/vaccines7040125vaccines7040125Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne BanyangvirusesCrystal A. Mendoza0Hideki Ebihara1Satoko Yamaoka2Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USADepartment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USADepartment of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USAIn the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans cause viral hemorrhagic fever-like disease leading to mortality rates ranging from 6−30% of the cases. The systemic inflammatory response syndrome (SIRS) associated with SFTSV infection is hypothesized to contribute significantly to pathology seen in patients. Despite the severe disease caused by HRTV and SFTSV, there are no approved therapeutics or vaccines. Investigation of the immune response during and following infection is critical to the generation of fully protective vaccines and/or supportive treatments, and overall understanding of viral immune evasion mechanisms may aid in the development of a new class of therapeutics.https://www.mdpi.com/2076-393X/7/4/125heartlandHRTVsevere fever with thrombocytopenia syndrome virusSFTSVSFTSBanyangvirusGuertu virusinterferon antagonism
collection DOAJ
language English
format Article
sources DOAJ
author Crystal A. Mendoza
Hideki Ebihara
Satoko Yamaoka
spellingShingle Crystal A. Mendoza
Hideki Ebihara
Satoko Yamaoka
Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
Vaccines
heartland
HRTV
severe fever with thrombocytopenia syndrome virus
SFTSV
SFTS
Banyangvirus
Guertu virus
interferon antagonism
author_facet Crystal A. Mendoza
Hideki Ebihara
Satoko Yamaoka
author_sort Crystal A. Mendoza
title Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
title_short Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
title_full Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
title_fullStr Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
title_full_unstemmed Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses
title_sort immune modulation and immune-mediated pathogenesis of emerging tickborne banyangviruses
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2019-09-01
description In the last decade, the emergence of several, novel tickborne viruses have caused significant disease in humans. Of interest are the tickborne banyangviruses: Severe fever with thrombocytopenia syndrome virus (SFTSV), Heartland virus (HRTV), and Guertu virus (GTV). SFTSV and HRTV infection in humans cause viral hemorrhagic fever-like disease leading to mortality rates ranging from 6−30% of the cases. The systemic inflammatory response syndrome (SIRS) associated with SFTSV infection is hypothesized to contribute significantly to pathology seen in patients. Despite the severe disease caused by HRTV and SFTSV, there are no approved therapeutics or vaccines. Investigation of the immune response during and following infection is critical to the generation of fully protective vaccines and/or supportive treatments, and overall understanding of viral immune evasion mechanisms may aid in the development of a new class of therapeutics.
topic heartland
HRTV
severe fever with thrombocytopenia syndrome virus
SFTSV
SFTS
Banyangvirus
Guertu virus
interferon antagonism
url https://www.mdpi.com/2076-393X/7/4/125
work_keys_str_mv AT crystalamendoza immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses
AT hidekiebihara immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses
AT satokoyamaoka immunemodulationandimmunemediatedpathogenesisofemergingtickbornebanyangviruses
_version_ 1716798030864187392